Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Amylyx Pharmaceuticals Inc (AMLX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Amylyx Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.780 -0.100    -5.32%
15:17:32 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,839,830
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.760 - 1.910
Amylyx Pharmaceuticals 1.780 -0.100 -5.32%

Amylyx Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Amylyx Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

237

Equity Type

ORD

Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate, AMX003 (sodium phenylbutyrate and taurursodiol, also known as ursodoxicoltaurine) for the treatment of amyotrophic lateral sclerosis (ALS). The Company is developing AMX0035 for other neurodegenerative diseases by leveraging knowledge and relationships in the neurodegenerative space. AMX0035 is a dual unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). Its development of antisense oligonucleotides (ASOs), including lead ASO AMX0114, which targets calpain-2 (CAPN2), a gene encoding calcium-dependent proteolytic enzyme which has been implicated in the pathogenesis of ALS and other neurodegenerative diseases.

Contact Information

Address 43 Thorndike Street
Cambridge, 02141
United States
Phone 617 682 0917
Fax -

Top Executives

Name Age Since Title
Joshua Cohen 30 2013 Co-Founder, Co-CEO & Director
Justin Klee 31 2013 Co-Founder, Co-CEO & Director
Rudolf Emile Tanzi 63 - Chairman of The Scientific Advisory Board
George Mclean Milne 78 2015 Independent Chairman of the Board
Walter A. Gilbert 90 2016 Special Advisor & Member of Advisory Board
Alan Edmund Walts 61 2017 Board Observer & Advisor
Sasha H. Bakhru - - Member of Scientific Advisory Board
Paul R. Fonteyne 61 2021 Independent Director
Daphne E. Quimi 56 2021 Independent Director
Karen Mindy Firestone 67 2023 Independent Director
Peter B. Finn - - Company Secretary & Member of Scientific Advisory Board
Bernhardt G. Zeiher 59 2024 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AMLX Comments

Write your thoughts about Amylyx Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Deneb Star
Deneb46 Mar 18, 2024 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will this be delisted? financials looking bad
JOSE MARCH
JOSE MARCH Mar 18, 2024 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No really, enough cash to make it
L VIB
L VIB Mar 09, 2024 8:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good times to buy???
Nhat Doan
Nhat Doan Mar 08, 2024 1:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BUYER WIN 💰💰💰 MUST SELL NOW 🤩🤩🤩
Nhat Doan
Nhat Doan Mar 08, 2024 9:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
💰💰💰 BUY COVER ALL AND ENJOIN YOUR WEEKEND 🤩👍👍👍
Nhat Doan
Nhat Doan Mar 08, 2024 7:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
🤔 IS IT REAL NEWS OR CHEATERS TO DUMP TO BUY OR COVER 😏
The Surviver
The Surviver Jun 03, 2022 3:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
15 - 18 Monday
Ab High
Ab High Mar 28, 2022 12:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
10.50
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email